MedTrace Logo

Hydration to Optimize Metabolism

NCT03422848 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 797

Last updated 2025-12-02

No results posted yet for this study

Summary

This study evaluates hydration (1.5 L of water daily during 1 year) in the lowering of blood glucose concentration in adults with signs of dehydration (elevated levels of the vasopressin marker copeptin and high urine osmolality). Half of participants will in addition to lifestyle advice receive extra water on top of their habitual fluid intake, and the other half (control) will receive only lifestyle advice.

Conditions

  • Glucose, High Blood

Interventions

DIETARY_SUPPLEMENT

Water

Increased daily water intake with 1.5 L of water on top of habitual water intake.

BEHAVIORAL

general life style advice

oral and written advice on diet and physical activity

Sponsors & Collaborators

  • Lund University

    collaborator OTHER

  • Danone Global Research & Innovation Center

    collaborator INDUSTRY

  • Region Skane

    lead OTHER

Principal Investigators

  • Olle Melander, M.D., Prof. · Lund University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-04-24
Primary Completion
2024-12-23
Completion
2025-11-03

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03422848 on ClinicalTrials.gov